News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Roche (JOBS) Says Still Commited to Genentech, Inc. (JOBS) Bid
November 25, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ZURICH, Nov 25 (Reuters) - Swiss drugmaker Roche Holding AG is still committed to a $43.7 billion bid to buy out U.S. biotech group Genentech Inc, a spokesman said on Tuesday.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Europe
Genentech, Inc.
Roche
MORE ON THIS TOPIC
Podcast
Sentiment at BIO soars as FDA resets, dealmaking evolves; Amgen’s Tavneos in hot water
July 1, 2026
·
2 min read
·
Jef Akst
Insights
Golden Triangle still dominates, but talent and capital gaps slow biotech growth
July 1, 2026
·
3 min read
·
Jennifer C. Smith-Parker
China
Deerfield bets up to $1.6B to snag autoimmune asset in China for Boulevard
June 30, 2026
·
1 min read
·
Annalee Armstrong
Mergers & acquisitions
Zymeworks adds lung disease drug, royalty deals in nearly $1B pick up of Theravance
June 29, 2026
·
2 min read
·
Annalee Armstrong
